BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
62 hedge funds and large institutions have $73M invested in BioDelivery Sciences International, Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 10 closing their positions.
127% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 11
43% more call options, than puts
Call options by funds: $465K | Put options by funds: $326K
14% more capital invested
Capital invested by funds: $64.3M → $73M (+$8.7M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 67 → 62 (-5)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$3.94M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.19M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.09M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$911K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$755K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$2.17M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.42M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$244K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$183K |
| 5 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
-$100K |
BDSI Hedge Fund Activity: Q3 2017 in Review
62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2017, worth a combined $73M — up 14% from $64.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of BDSI and 6 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 25 added.
The largest buyer was Royce & Associates, opening a new position worth an estimated $3.94M. The largest seller was Broadfin Capital, cutting an estimated $2.17M.
- 62 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2017, down from 67 in Q2 2017.
- Funds reported $73M of BioDelivery Sciences International, Inc. stock for Q3 2017, up 14% quarter-over-quarter.
- 6 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2017 and 10 closed out, a net change of -4 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2017 was Royce & Associates, an estimated $3.94M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2017 was Broadfin Capital, an estimated $2.17M sold.
Based on aggregated 13F filings for Q3 2017.